´çƯÀÌ¿Í ´çºñƯÀÌ Ç÷´çÃøÁ¤±âÀÇ Â÷ÀÌ
½ÃÁß¿¡ ÆÇ¸Å ÁßÀÎ Ç÷´ç±â Áß¿¡´Â ´çƯÀÌ Ç÷´çÃøÁ¤±â¿Í ´çºñƯÀÌ Ç÷´çÃøÁ¤±â°¡ ÀÖ½À´Ï´Ù. Ç÷´çÀ̶ó´Â °ÍÀº Ç÷¾× ³»ÀÇ Æ÷µµ´ç¸¸À» ÀǹÌÇÕ´Ï´Ù. ´çƯÀÌ Ç÷´çÃøÁ¤±â´Â Ç÷¾× ³»ÀÇ Æ÷µµ´ç(±Û·çÄÚ½º glucose) ¸¸À» ±¸ºÐÇÏ¿© Ç÷´çÀ¸·Î ÃøÁ¤ÇÕ´Ï´Ù.
¹Ý¸é, ´çºñƯÀÌ Ç÷´çÃøÁ¤±â´Â Æ÷µµ´ç À̿ܿ¡µµ ´Ù¸¥ ´ç¿¡µµ ¹ÝÀÀÇÏ¿© ½ÇÁ¦º¸´Ù ³ôÀº Ç÷´çÃøÁ¤°á°ú¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.
´Ù¸¥ Á¾·ùÀÇ ´çÀº ÁÖ·Î º´¿ø¿¡¼ »ç¿ëµÇ´Â
1)¸é¿ª±Û·ÎºÒ¸° ÁÖ»ç(°ñ¼öÀ̽ÄȯÀÚ, °£À̽ÄȯÀÚ, ±æ¶û¹Ù·¹ ÁõÈıº, Ư¹ß¼º Ç÷¼ÒÆÇ °¨¼Ò¼º ÀÚ¹ÝÁõ(TIP), °¡¿Í»çŰº´¿¡ ÁÖ»ç)
2)¾ÆÀÌÄÚµ¦½ºÆ®¸° º¹¸·Åõ¼®¾×(º¹¸·Åõ¼®È¯ÀÚ¿¡°Ô »ç¿ë)
3)°¥¶ôÅä¿À½º ºÎÇϰ˻ç¾×(°£ ±â´É °Ë»çÀÇ ÀÏÁ¾)
4)ÀÚÀϷοÀ½º ºÎÇϰ˻ç¾×(Àå ±â´É °Ë»çÀÇ ÀÏÁ¾) µî¿¡ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.
ÀÌ·± °æ¿ì, ´çºñƯÀÌ Ç÷´ç±â·Î Ç÷´çÀ» Àç¸é, ´Ù¸¥ ´ç¿¡µµ ¹ÝÀÀÇÏ¿©, ½ÇÁ¦ Ç÷´çÄ¡º¸´Ù ³ô°Ô ÃøÁ¤µÉ ¼ö ÀÖ½À´Ï´Ù.
½ÇÁ¦º¸´Ù ³ô°Ô ÃøÁ¤µÈ Ç÷´ç°Ë»ç°á°ú·Î ÇØ´ç ȯÀڵ鿡°Ô Àν¶¸°À» À߸ø ó¹æÇÏ´Â °æ¿ì, ÀúÇ÷´ç, È¥¼ö»óÅ¿¡ À̸¦ ¼öµµ ÀÖ½À´Ï´Ù.
ij³ª´Ù Á¤ºÎ¿¡¼´Â ¾ÆÀÌÄÚµ¦½ºÆ®¸° º¹¸·Åõ¼® Ä¡·á¸¦ ¹Þ´Â ½ÅºÎÀü ȯÀÚ¿¡°Ô ÀÌ·± ¹®Á¦°¡ ¹ß»ýÇÏ¿´À½À» º¸°í ¹Þ¾Ò½À´Ï´Ù.
µû¶ó¼, ij³ª´Ù Á¤ºÎ¿¡¼´Â ´çºñƯÀÌ Ç÷´çÃøÁ¤±â¸¦ »ç¿ëÇØ ¹ß»ýÇÒ ¼ö ÀÖ´Â À߸øµÈ Ç÷´çÃøÁ¤À» ¿¹¹æÇϱâ À§ÇØ ´çƯÀÌ(Glucose Sepcific) À¯ÇüÀÇ Ç÷´çÃøÁ¤±â·Î ±³Ã¼ »ç¿ëÇÒ °ÍÀ» ±Ç°íÇÏ¿´½À´Ï´Ù..
±Ù°ÅÀÚ·á
1. ÀÇ·á±â±â ¾ÈÀü¼º ¼ÇÑ(½ÄǰÀǾàǰ¾ÈÀüû, 2008. 12. 18)
2. ij³ª´Ù Á¤ºÎ 2008. 12. 16ÀÏÀÚ ¹ß°£ ¡°Notice to Hospitals¡±
Health Canada Issued Important Safety Information on Possible interference oficodextrin,
intravenous immunoglobulins, galactose d-xylose with certain blood glucose meters |